“☎베스트토토먹튀없음【평생베스트.com】베스트토토안전☎”的搜索结果，显示 141-150 项，共有 7050 项

1. 整合医学与健康- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

4. 皮肤科- 临床试验- 妙佑医疗国际

   ... best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma. A Study to Evaluate Perceptions of Midline ...

5. 林奇综合征- 医生与科室- 妙佑医疗国际

   了解这种因遗传基因导致的疾病，这些基因会增加结肠癌、子宫内膜癌和其他类型癌症的风险。

6. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to describe a practical and reproducible radiographic view that can be used in the work-up of ulnocarpal impaction. Aggressive ...

7. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our ...

8. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to compare the fecal microbiota of patients with mild, moderate and severe Coronary Artery Disease (CAD) by ...

9. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...